Publication: STAT
STAT
has 48% among publications.
BS Score: 2%.
Articles analyzed: 15.
Words analyzed: 23,410.
Analyzed articles
STAT
- By Tara Bannow
- 7/2/2026, 7:52 PM
Biased Writer Voice 71.6% - Framing Effect 47.7% - Negativity Bias 35.2%
Medicare wants to slash payments to hospitals for drugs acquired through the 340B drug discount program by more than a third beginning next year, after the agency said its surveys found some patients paid more for the drugs than the hospitals did. Under a proposal released Thursday, Medicare would pay hospitals for 340B drugs at their... more
STAT
- By Ed Silverman
- 7/2/2026, 7:52 PM
Hasty Generalization 41.3% - Framing Effect 33.5% - Biased Writer Voice 33.5%
Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks to hospitals that participate in a federal drug discount program but have refused to provide the company with claims data. In a letter to Department of Health and Human Services Secretary Robert F. Kennedy Jr., the... more
STAT
- By Ed Silverman
- 7/2/2026, 5:32 PM
Indoctrination 29.1% - Halo Effect 22.4% - Appeal to Authority 22.4%
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a... more
STAT
- By Ed Silverman
- 7/2/2026, 12:54 PM
Biased Writer Voice 78.6% - Framing Effect 59.3% - Negativity Bias 32.4%
In a victory for the pharmaceutical industry, a federal judge blocked a Colorado state panel from placing a cap on the price of a blockbuster drug sold by Amgen after deciding the company is “likely to be significantly harmed.” The ruling pauses a controversial, first-in-the-nation move by the Colorado Prescription Drug Affordability... more
STAT
- By Elizabeth Cooney
- 7/1/2026, 10:30 PM
Post Hoc (False Cause) 13.1% - Negativity Bias 12.8% - Ambiguity (Equivocation) 11.7%
People with obesity have worse cardiovascular health than people with normal weight, especially as they get older, right? Not necessarily. People over 40 with obesity appear to have both their blood pressure and cholesterol under control at levels rivaling their peers with normal body mass index, research published Wednesday in the... more
STAT
- By Brittany Trang
- 7/1/2026, 3:11 PM
Attempt to Sell a Product or Service 37.8% - Anecdotal 27.6% - Appeal to Authority 23.6%
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. For the last several weeks my friend and I have been obsessed with the daily game Multiplet, which, when you complete the... more
STAT
- By Adam Feuerstein
- 7/1/2026, 11:38 AM
Optimism Bias 50.9% - Attempt to Sell a Product or Service 50.9% - Ambiguity (Equivocation) 42.3%
The Food and Drug Administration on Tuesday approved a personalized T-cell therapy from Orca Bio, a private biotech company, that reduces the risk of a debilitating immune reaction in patients with blood cancers undergoing stem cell transplants. The Orca therapy, called Tregzi, represents an alternative approach to traditional... more
STAT
- By Adam Feuerstein
- 7/1/2026, 8:30 AM
Attempt to Sell a Product or Service 56.5% - Appeal to Authority 25.5% - Negativity Bias 20.9%
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx Pharmaceuticals: Results from the Phase 3 LUCIDITY study of avexitide in post-bariatric hypoglycemia, a rare metabolic condition that causes severe drops in blood sugar. Biogen: In May, the company announced results from a... more
STAT
- By Krutika Kuppalli, Placide Mbala
- 7/1/2026, 8:30 AM
Indoctrination 22.2% - Post Hoc (False Cause) 15.9% - Appeal to Authority 12%
As the ongoing Bundibugyo Ebola outbreak spreads across the Democratic Republic of the Congo and Uganda, global attention has understandably focused on the absence of licensed vaccines and therapeutics for this rare species of Ebola virus. Yet one of the outbreak’s most consequential failures has received far less attention: our... more
STAT
- By Isabella Cueto, Lev Facher
- 7/1/2026, 8:30 AM
Negativity Bias 79.4% - Biased Writer Voice 69.8% - Confirmation Bias 37.7%
Len Lichtenfeld had a long-overdue apology to make. He was haunted in late 2024 by an exchange with a New York Times reporter almost a decade earlier, during which Lichtenfeld defended the American Cancer Society’s official stance that a drink or two a day was safe, even for cancer prevention. There was mounting evidence to the contrary,... more